Annual Current Liabilities
$1.96 M
-$22.21 M-91.91%
December 31, 2023
Summary
- As of February 7, 2025, TCRT annual total current liabilities is $1.96 million, with the most recent change of -$22.21 million (-91.91%) on December 31, 2023.
- During the last 3 years, TCRT annual current liabilities has fallen by -$16.41 million (-89.35%).
- TCRT annual current liabilities is now -91.91% below its all-time high of $24.17 million, reached on December 31, 2022.
Performance
TCRT Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$826.00 K
-$81.00 K-8.93%
September 30, 2024
Summary
- As of February 7, 2025, TCRT quarterly total current liabilities is $826.00 thousand, with the most recent change of -$81.00 thousand (-8.93%) on September 30, 2024.
- Over the past year, TCRT quarterly current liabilities has dropped by -$81.00 thousand (-8.93%).
- TCRT quarterly current liabilities is now -98.63% below its all-time high of $60.18 million, reached on September 30, 2018.
Performance
TCRT Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
TCRT Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -91.9% | -8.9% |
| 3 y3 years | -89.3% | -97.1% |
| 5 y5 years | -79.4% | -95.7% |
TCRT Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -91.9% | at low | -97.5% | at low |
| 5 y | 5-year | -91.9% | at low | -97.5% | at low |
| alltime | all time | -91.9% | >+9999.0% | -98.6% | >+9999.0% |
Alaunos Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $826.00 K(-8.9%) |
| Jun 2024 | - | $907.00 K(-26.9%) |
| Mar 2024 | - | $1.24 M(-36.6%) |
| Dec 2023 | $1.96 M(-91.9%) | $1.96 M(-58.2%) |
| Sep 2023 | - | $4.68 M(-7.4%) |
| Jun 2023 | - | $5.05 M(-70.4%) |
| Mar 2023 | - | $17.06 M(-29.4%) |
| Dec 2022 | $24.17 M(+50.7%) | $24.17 M(-26.5%) |
| Sep 2022 | - | $32.87 M(+22.8%) |
| Jun 2022 | - | $26.77 M(+26.1%) |
| Mar 2022 | - | $21.23 M(+32.4%) |
| Dec 2021 | $16.04 M(-12.7%) | $16.04 M(-43.1%) |
| Sep 2021 | - | $28.17 M(+107.3%) |
| Jun 2021 | - | $13.59 M(-28.3%) |
| Mar 2021 | - | $18.96 M(+3.2%) |
| Dec 2020 | $18.37 M(+46.6%) | $18.37 M(-4.9%) |
| Sep 2020 | - | $19.32 M(+12.9%) |
| Jun 2020 | - | $17.11 M(+3.2%) |
| Mar 2020 | - | $16.58 M(+32.4%) |
| Dec 2019 | $12.53 M(+32.1%) | $12.53 M(+12.1%) |
| Sep 2019 | - | $11.18 M(+7.5%) |
| Jun 2019 | - | $10.40 M(+24.7%) |
| Mar 2019 | - | $8.34 M(-12.1%) |
| Dec 2018 | $9.48 M(-54.5%) | $9.48 M(-84.2%) |
| Sep 2018 | - | $60.18 M(+546.2%) |
| Jun 2018 | - | $9.31 M(-7.4%) |
| Mar 2018 | - | $10.06 M(-51.8%) |
| Dec 2017 | $20.86 M(+31.9%) | $20.86 M(+14.7%) |
| Sep 2017 | - | $18.19 M(+13.8%) |
| Jun 2017 | - | $15.99 M(-8.5%) |
| Mar 2017 | - | $17.46 M(+10.5%) |
| Dec 2016 | $15.81 M(-12.8%) | $15.81 M(+0.4%) |
| Sep 2016 | - | $15.74 M(-1.8%) |
| Jun 2016 | - | $16.04 M(-7.2%) |
| Mar 2016 | - | $17.27 M(-4.7%) |
| Dec 2015 | $18.12 M(+67.4%) | $18.12 M(-38.8%) |
| Sep 2015 | - | $29.63 M(+126.0%) |
| Jun 2015 | - | $13.11 M(+25.0%) |
| Mar 2015 | - | $10.49 M(-3.1%) |
| Dec 2014 | $10.83 M(+39.0%) | $10.83 M(-7.5%) |
| Sep 2014 | - | $11.70 M(+8.5%) |
| Jun 2014 | - | $10.79 M(+46.7%) |
| Mar 2014 | - | $7.35 M(-5.6%) |
| Dec 2013 | $7.79 M(-58.7%) | $7.79 M(-41.7%) |
| Sep 2013 | - | $13.36 M(-36.4%) |
| Jun 2013 | - | $21.00 M(+3.1%) |
| Mar 2013 | - | $20.36 M(+7.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $18.86 M(+41.2%) | $18.86 M(-13.2%) |
| Sep 2012 | - | $21.74 M(+22.3%) |
| Jun 2012 | - | $17.78 M(+24.0%) |
| Mar 2012 | - | $14.33 M(+7.2%) |
| Dec 2011 | $13.36 M(+270.0%) | $13.36 M(+13.5%) |
| Sep 2011 | - | $11.77 M(+35.4%) |
| Jun 2011 | - | $8.69 M(+32.8%) |
| Mar 2011 | - | $6.54 M(+81.2%) |
| Dec 2010 | $3.61 M(+16.7%) | $3.61 M(-12.0%) |
| Sep 2010 | - | $4.11 M(+78.1%) |
| Jun 2010 | - | $2.31 M(-18.6%) |
| Mar 2010 | - | $2.83 M(-8.5%) |
| Dec 2009 | $3.10 M(-46.4%) | $3.10 M(-11.9%) |
| Sep 2009 | - | $3.51 M(+4.1%) |
| Jun 2009 | - | $3.38 M(-14.7%) |
| Mar 2009 | - | $3.96 M(-31.5%) |
| Dec 2008 | $5.78 M(-8.4%) | $5.78 M(+1.3%) |
| Sep 2008 | - | $5.70 M(-7.8%) |
| Jun 2008 | - | $6.18 M(-8.2%) |
| Mar 2008 | - | $6.73 M(+6.7%) |
| Dec 2007 | $6.31 M(+114.6%) | $6.31 M(+24.4%) |
| Sep 2007 | - | $5.07 M(+32.6%) |
| Jun 2007 | - | $3.82 M(+13.9%) |
| Mar 2007 | - | $3.36 M(+14.3%) |
| Dec 2006 | $2.94 M(+30.3%) | $2.94 M(-10.4%) |
| Sep 2006 | - | $3.28 M(+24.3%) |
| Jun 2006 | - | $2.64 M(+32.8%) |
| Mar 2006 | - | $1.99 M(-11.8%) |
| Dec 2005 | $2.25 M(+41.9%) | $2.25 M(+29.0%) |
| Sep 2005 | - | $1.75 M(>+9900.0%) |
| Jun 2005 | - | $9900.00(-43.8%) |
| Mar 2005 | - | $17.60 K(-98.9%) |
| Dec 2004 | $1.59 M(+6084.0%) | $1.59 M(>+9900.0%) |
| Sep 2004 | - | $14.90 K(+8.8%) |
| Jun 2004 | - | $13.70 K(-48.3%) |
| Mar 2004 | - | $26.50 K(+3.1%) |
| Dec 2003 | $25.70 K(+44.4%) | $25.70 K(+32.5%) |
| Sep 2003 | - | $19.40 K(+26.8%) |
| Jun 2003 | - | $15.30 K(-33.5%) |
| Mar 2003 | - | $23.00 K(+29.2%) |
| Dec 2002 | $17.80 K(+158.0%) | $17.80 K(+278.7%) |
| Sep 2002 | - | $4700.00(-45.3%) |
| Jun 2002 | - | $8600.00(+65.4%) |
| Mar 2002 | - | $5200.00(-24.6%) |
| Dec 2001 | $6900.00 | $6900.00(-17.9%) |
| Sep 2001 | - | $8400.00(-19.2%) |
| Jun 2001 | - | $10.40 K |
FAQ
- What is Alaunos Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Alaunos Therapeutics?
- What is Alaunos Therapeutics annual current liabilities year-on-year change?
- What is Alaunos Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Alaunos Therapeutics?
- What is Alaunos Therapeutics quarterly current liabilities year-on-year change?
What is Alaunos Therapeutics annual total current liabilities?
The current annual current liabilities of TCRT is $1.96 M
What is the all time high annual current liabilities for Alaunos Therapeutics?
Alaunos Therapeutics all-time high annual total current liabilities is $24.17 M
What is Alaunos Therapeutics annual current liabilities year-on-year change?
Over the past year, TCRT annual total current liabilities has changed by -$22.21 M (-91.91%)
What is Alaunos Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of TCRT is $826.00 K
What is the all time high quarterly current liabilities for Alaunos Therapeutics?
Alaunos Therapeutics all-time high quarterly total current liabilities is $60.18 M
What is Alaunos Therapeutics quarterly current liabilities year-on-year change?
Over the past year, TCRT quarterly total current liabilities has changed by -$81.00 K (-8.93%)